Top View
- PSILOCIN PSILOCYBIN Latest Revision: June 27, 2005
- Psychotoxic Or Psychedelic G
- The Pharmacology of Psilocybin
- The Therapeutic Potential of Psilocybin
- A Technique for the Rapid Isolation and Identification of Psilocin from Psilocin/Psilocybin- Containing Mushrooms
- Analysis of Psilocybin and Psilocin in Psilocybe ´ Subcubensis GUZMAN by Ion Mobility Spectrometry and Gas Chromatography–Mas
- The Serotonin Hallucinogen 5-Meo-DMT Alters Cortico-Thalamic Activity In
- EXECUTIVE ORDER Subject: Initiative No
- Bufotenine - a Hallucinogen in Ancient Snuff Powders of South America and a Drug of Abuse on the Streets of New York City
- Metabolism of Psilocybin and Psilocin: Clinical and Forensic Toxicological Relevance
- Consciousness, Neurons, and Laughing Gas
- The Pharmacology of D-Lysergic Acid Diethylamide (LSD)
- Altered States of Consciousness Drug‐Induced States David E
- Occurrence and Use of Hallucinogenic Mushrooms Containing Psilocybin Alkaloids
- Biomedical Significance of Tryptamine
- Hallucinogens and Dissociative Drug Use and Addiction
- Fungal Hallucinogens Psilocin, Ibotenic Acid, and Muscimol: Analytical Methods and Biologic Activities
- Author Version Receptor Interaction Profiles of Novel Psychoactive
- Characterization of the Discriminative Stimulus Effects of Nitrous Oxide
- The Hallucinogenic World of Tryptamines: an Updated Review
- Psychoactive Substances of Natural Origin: Toxicological Aspects, Therapeutic Properties and Analysis in Biological Samples
- Receptor Binding Profiles and Behavioral Pharmacology of Ring
- Receptor Interaction Profiles of Novel Psychoactive Tryptamines Compared
- Decriminalizing Entheogenic Plants
- Something New About Something Old: a 10-Year Follow-Up on Classical and New Psychoactive Tryptamines and Results of Analysis
- Toxicology and Analysis of Psychoactive Tryptamines
- The Relationship Between Psilocybin/Psilocin Plasma Levels and Receptor Occupancy: PET Imaging with 11C-Cimbi-36
- LSD – My Problem Child by Albert Hofmann
- BUFOTENINE Latest Revision: August 16, 2005
- Psilocybin Investigator's Brochure
- Lysergic Acid Diethylamide (LSD) and Psilocybin for the Manage- Ment of Patients with Persistent Pain: a Potential Role? Pain Management, 8 (3)
- Hallucinogens: LSD, Peyote, Psilocybin, and PCP
- Psychedelic Harm Reduction & Integration in the Community
- Quantitation of Psilocybin and Psilocybin in Mushroom by LC-MS
- 2 Cases of Acute Confusional State with Autonomic Symptoms After Designer Tryptamine Abuse Hisashi Ito*, Shigeru Fukutake and Tetsumasa Kamei